Clinical and laboratory differences between pediatric hospitalized patients with sickle cell disease infected or not by SARS-CoV-2.
Gabriella Mafra EliaTulio KonstantynerRafaela Pilotto NaisAndreia Regina Augusto Dos SantosAndrea AngelJosefina Aparecida Pellegrini BragaPublished in: Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo (2023)
Pediatric hospitalized patients with sickle cell disease infected by SARS-CoV-2 had more comorbidities and had a decrease in eosinophil count between hospital admission and the last medical appointment.